Nanoparticle with polynucleotide binding site and method of making thereof

Patent metadata

Field	Value
Publication number	US-2024124916-A1
Application number	US-202318467770-A
Country	US
Kind code	A1
Filing date	Sep 15, 2023
Priority date	Sep 16, 2022
Publication date	Apr 18, 2024
Grant date	—

Abstract

The present disclosure relates to a nanoparticle including a first layer including a first polymer and a first plurality of accessory oligonucleotides, a second layer including a second polymer and a single template site for bonding a template polynucleotide, and a third layer including a third polymer and a second plurality of accessory oligonucleotides. Also described herein is a method of making said nanoparticle, including “dip-coating,” e.g., successively dipping a surface with wettable nanodomains in different polymer solutions. Further described herein is a method of making the nanoparticles by forming them in nanowells and subsequently releasing them from the nanowells. Also described herein is a method of attaching the nanoparticle to a substrate and amplifying the template polynucleotide using a polymerase.

First claim

1 . A nanoparticle comprising:
a first layer comprising a first polymer and a first plurality of accessory sites, a second layer comprising a second polymer comprising a single template site for bonding a template polynucleotide, and a third layer comprising a third polymer and a second plurality of accessory sites, wherein the second layer is between the first layer and the third layer.

2 . The nanoparticle of claim 1 , wherein one or both of:
(i) the first polymer is a hydrophilic polymer; and (ii) the third polymer is a lipophilic polymer.

3 . The nanoparticle of claim 2 , wherein one or both of:
(i) the hydrophilic polymer is selected from a natural polyacrylamide, a polyethylene imine, a polypeptide, a polysaccharide, a polyvinyl alcohol, a poly acrylic acid, a poly allylamine, a poly-styrene sulfonate, or a poly-oxazoline; and (ii) the lipophilic polymer is selected from an isopropylacrylamide, an acrylic, an epoxy, a polyethylene, a polystyrene, a polyvinyl a polymethyl sulfonate, a polyurethane, and a fluorinated polymer.

4 - 5 . (canceled)

6 . The nanoparticle of claim 1 , wherein the first polymer and the third polymer are each independently chosen from a poly(vinylidene fluoride), a polystyrene, an epoxy polymer, a (meth)acrylate polymer, a polydimethylsiloxane, an SiO 2 -containing polymer, a poly(lactic-co-glycolic acid) polymer, a perfluorinated polymer, an azapa-co-acrylamide polymer (PAZNAM), a poly(N-(5-azidoacetamidylpentyl)acrylamide-co-acrylamide) (PAZAM) polymer, a poly(o-nitrobenzyl-masked acrylamide-co-acrylamide) copolymer, a poly(benzopyrone-masked acrylamide-co-acrylamide) copolymer, a poly(aminotriazole-acrylamide-co-acrylamide) copolymer, a poly(thiotriazole-acrylamide-co-acrylamide) copolymer, a poly(alkenyltriazole-acrylamide-co-acrylamide) copolymer, and a thiol/ene cross-linkable monomer mix.

7 . The nanoparticle of claim 1 , wherein one or more of:
(i) the first polymer is polyacrylamide; (i) the third polymer is isopropyl acrylamide; and (ii) the second polymer is methacylate.

8 . The nanoparticle of claim 1 , wherein the second polymer is a copolymer of the first polymer and the third polymer.

9 - 10 . (canceled)

11 . The nanoparticle of claim 1 , further comprising one or both of a first plurality of accessory oligonucleotides attached to the first plurality of accessory sites and a second plurality of accessory oligonucleotides attached to the second plurality of accessory sites.

12 . The nanoparticle of claim 11 , wherein one or both of the first plurality of accessory oligonucleotides and the second plurality of accessory oligonucleotides comprise one or both of forward primers and reverse primers, wherein sequences of the forward primers and sequences of the reverse primers permit amplifying the template polynucleotide by a polymerase.

13 . The nanoparticle of claim 12 , wherein forward primers of the first plurality of accessory oligonucleotides and reverse primers of the second plurality of accessory oligonucleotides, or reverse primers of the first plurality of accessory oligonucleotides and forward primers of the second plurality of accessory oligonucleotides, are cleavable, and other primers of the first and second pluralities of accessory oligonucleotides are uncleavable.

14 . The nanoparticle of claim 1 , wherein the single template site comprises:
a type of attachment site for a template anchor oligonucleotide or the template anchor oligonucleotide.

15 . A method comprising:
attaching the nanoparticle of claim 1 to a substrate and amplifying the template polynucleotide using a polymerase.

16 - 17 . (canceled)

18 . The method of claim 15 , wherein one or both of:
(i) the substrate is silanized TiO 2 or fluoro-silane TiO 2 ; and (ii) attaching comprises hybridizing a forward primer or a reverse primer to an oligonucleotide attached to the substrate.

19 . A method of making a nanoparticle comprising:
coating wettable nanodomains of a substrate surface with a solubilizable polymer, wherein the wettable nanodomains are separated by non-wettable interstices; coating the solubilizable polymer with a first polymer, wherein the first polymer comprises a first plurality of accessory sites; coating the first polymer with a second polymer, wherein the second polymer comprises a single template site; coating the second polymer with a third polymer, wherein the third polymer comprises a second plurality of accessory sites; and solubilizing the solubilizable polymer to release the nanoparticle.

20 . The method of claim 19 , wherein one or both of:
(i) the first plurality of accessory sites comprises a first plurality of accessory oligonucleotides or the first plurality of accessory sites comprises a first type of attachment site for the first plurality of accessory oligonucleotides but not for a second plurality of accessory oligonucleotides; (ii) the second plurality of accessory sites comprises a second plurality of accessory oligonucleotides or the second plurality of accessory sites comprises a second type of attachment site for the second plurality of accessory oligonucleotides but not for the first plurality of accessory oligonucleotides; and (iii) the single template site comprises:
a type of attachment site for a template anchor oligonucleotide and the method further comprises attaching the template anchor oligonucleotide to the single template site; or
the template anchor oligonucleotide.

21 . (canceled)

22 . The method of claim 20 , wherein one or both of:
(i) attaching the first plurality of accessory oligonucleotides to the first plurality of accessory sites occurs before coating the solubilizable polymer with the first polymer or after coating the solubilizable polymer with the first polymer and before the solubilizing, or after the solubilizing; and (ii) attaching the second plurality of accessory oligonucleotides to the second plurality of accessory sites occurs before coating the solubilizable polymer with the first polymer or after coating the solubilizable polymer with the first polymer and before the solubilizing, or after the solubilizing.

23 . (canceled)

24 . The method of claim 19 , wherein the solubilizable polymer is a sulfonate, a sugar, or a phenol.

25 . The method of claim 24 , wherein the solubilizable polymer is poly(sodium 4-styrenesulfonate) or poly-4-vinylphenol.

26 . A method comprising:
forming a nanoparticle in a nanowell, wherein forming comprises: polymerizing a first polymer, wherein the first polymer comprises a first plurality of accessory sites; polymerizing a second polymer on the first polymer, wherein the second polymer comprises a single template site; and polymerizing a third polymer on the second polymer, wherein the third polymer comprises a second plurality of accessory sites.

27 . The method of claim 26 , wherein one or more of:
(i) the first plurality of accessory sites comprises a first plurality of accessory oligonucleotides or the first plurality of accessory sites comprises a first type of attachment site for the first plurality of accessory oligonucleotides but not for a second plurality of accessory oligonucleotides; (ii) the second plurality of accessory sites comprises a second plurality of accessory oligonucleotides or the second plurality of accessory sites comprises a second type of attachment site for the second plurality of accessory oligonucleotides but not for t

Assignees

• Illumina Cambridge Ltd

Inventors

• Szemjonov Alexandra
• La Rosa Angelo
• Artioli Gianluca
• Von Hatten Xavier
• Richez Alexandre

Classifications

• C12Q2565/518

  characterised by the immobilisation of the nucleic acid sample or target · CPC title

• C12Q2565/543

  characterised by the use of two or more capture oligonucleotide primers in concert, e.g. bridge amplification · CPC title

• C12Q2563/155

  Particles of a defined size, e.g. nanoparticles · CPC title

• C12Q1/6834 Primary

  Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title

• C12Q1/6806 Primary

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title